Directed new share issue in Active Biotech (SE) — SEK 375 million

Carnegie acted as joint lead manager and book-runner in the directed new share issue of 2.5 million shares at a price of SEK 150 per share. Active Biotech is a biotechnology company with focus on autoimmune/inflammatory diseases and cancer.January, 2011.